Gene · 4880
Papers1,757
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,757
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigation of Potential cGMP-Specific PDE V and Aminopeptidase N Inhibitors of Allium ampeloprasum L. and Its Bioactive Components: Kinetic and Molecular Docking Studies. | Int J Mol Sci | 2023 | 37686129 | PubTator, text mining | PubMed |
| Decreased oocyte quality in patients with endometriosis is closely related to abnormal granulosa cells. | Front Endocrinol (Lausanne) | 2023 | 37664845 | PubTator, text mining | PubMed |
| Pharmacological and Genetic Disruption of C-Type Natriuretic Peptide (nppcl) Expression in Zebrafish (Danio rerio) Causes Stunted Growth during Development. | Int J Mol Sci | 2023 | 37629102 | PubTator, text mining | PubMed |
| Clinical and genetic evaluation of children with short stature of unknown origin. | BMC Med Genomics | 2023 | 37605180 | PubTator, text mining | PubMed |
| Hub gene associated with prognosis in bladder cancer is a novel therapeutic target. | PeerJ | 2023 | 37601252 | PubTator, text mining | PubMed |
| Natriuretic Peptide Signaling in Uterine Biology and Preeclampsia. | Int J Mol Sci | 2023 | 37569683 | PubTator, text mining | PubMed |
| Effect of Systemic Inflammation in the CNS: A Silent History of Neuronal Damage. | Int J Mol Sci | 2023 | 37569277 | PubTator, text mining | PubMed |
| NPRC deletion mitigated atherosclerosis by inhibiting oxidative stress, inflammation and apoptosis in ApoE knockout mice. | Signal Transduct Target Ther | 2023 | 37553374 | PubTator, text mining | PubMed |
| NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways. | Sci Adv | 2023 | 37531438 | PubTator, text mining | PubMed |
| Short histological kaleidoscope - recent findings in histology. Part III. | Rom J Morphol Embryol | 2023 | 37518868 | PubTator, text mining | PubMed |
| Predicting Therapeutic Efficacy of Pharmacological Treatments in Children with Postural Orthostatic Tachycardia Syndrome: A Mini-Review. | Children (Basel) | 2023 | 37508589 | PubTator, text mining | PubMed |
| Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH. | Orphanet J Rare Dis | 2023 | 37501190 | PubTator, text mining | PubMed |
| C-type natriuretic peptide induces inotropic and lusitropic effects in human 3D-engineered cardiac tissue: Implications for the regulation of cardiac function in humans. | Exp Physiol | 2023 | 37493451 | PubTator, text mining | PubMed |
| WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective. | Diseases | 2023 | 37489441 | PubTator, text mining | PubMed |
| Oncostatin M, Serpins, and Oxidative Stress in Extracellular Matrix Remodeling and Arteriovenous Fistula Maturation. | Cardiol Cardiovasc Med | 2023 | 37484520 | PubTator, text mining | PubMed |
| The spectrum of in vitro maturation in clinical practice: the current insight. | Front Endocrinol (Lausanne) | 2023 | 37455921 | PubTator, text mining | PubMed |
| IVM of human immature oocytes for infertility treatment and fertility preservation. | Reprod Med Biol | 2023 | 37441160 | PubTator, text mining | PubMed |
| The FSH-mTOR-CNP signaling axis initiates follicular antrum formation by regulating tight junction, ion pumps, and aquaporins. | J Biol Chem | 2023 | 37414146 | PubTator, text mining | PubMed |
| Decreased level of serum NT-proCNP associates with disease severity in COVID-19. | Respir Res | 2023 | 37386635 | PubTator, text mining | PubMed |
| Burden and Treatment of Achondroplasia: A Systematic Literature Review. | Adv Ther | 2023 | 37382866 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4880/papers?page=8